CORRECTION: Agereh Expands Intelligent Transportation Portfolio with Launch of Smart Door Sensor™ and retains Hillside C&M Inc. 
Mr Liu Xiaojun, on behalf of Fufeng Group, has fully completed the acquisition of Viva World Trade, Inc. Share Capital Consolidation and Commencement of trading in the New Tiziana Shares on NASDAQ
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH…
Linneo Health announces GMP certification of quality control laboratory by AEMPS
Linneo Health announces GMP certification of quality control laboratory by AEMPS Company holds one of…
Ultimovacs Receives Dual FDA Fast Track Designation for UV1 in Advanced Malignant Melanoma
UV1 as add-on therapy to checkpoint inhibitors awarded Fast Track designation Provides for potentially expedited…
argenx to Report Third Quarter 2021 Financial Results and Business Update on October 28, 2021
October 21, 2021 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology…
MDxHealth Provides Q3-2021 Business Update
NEWS RELEASE – REGULATED INFORMATION21 OCTOBER 2021, 07:00 A.M. CET MDxHealth Provides Q3-2021 Business Update…
Ventyx Biosciences Announces Pricing of Upsized Initial Public Offering
ENCINITAS, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (“Ventyx”), a clinical-stage biopharmaceutical…
23andMe to Report FY2022 Second Quarter Financial Results on November 10, 2021
SUNNYVALE, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a…
FDA expands approval of Dupixent® (dupilumab) to include children aged 6 to 11 years with moderate-to-severe asthma
FDA expands approval of Dupixent® (dupilumab) to include children aged 6 to 11 years with…
The New England Journal of Medicine publishes the results of the NATIVE Phase IIb clinical trial with lanifibranor in NASH
In the Phase IIb NATIVE, lanifibranor met both the primary and key secondary endpoints, including…
Checkmate Pharmaceuticals Announces Webcast on Innate Immune Modulators and Vidutolimod (CMP-001)
Live presentation and Q&A moderated by Jefferies Equity Research on Tuesday, October 26, 2021 at…
Neurona Therapeutics Appoints Brad Margus to its Board of Directors
SAN FRANCISCO, Oct. 20, 2021 (GLOBE NEWSWIRE) — Neurona Therapeutics, a biotherapeutics company advancing restorative…
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
SAN DIEGO, Oct. 20, 2021 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage…
ADMA Biologics Announces Proposed Public Offering of Common Stock
RAMSEY, N.J. and BOCA RATON, Fla., Oct. 20, 2021 (GLOBE NEWSWIRE) — ADMA Biologics, Inc….
Radius Health to Announce Third Quarter 2021 Financial Results, Host Conference Call and Live Webcast on Monday, November 8, 2021
BOSTON, Oct. 20, 2021 (GLOBE NEWSWIRE) — Radius Health, Inc. (NASDAQ: RDUS) announced today that…
ImCheck Publishes Comprehensive Overview of the Development Results of Its First-in-class Cancer Immunotherapeutic Targeting BTN3A to Activate Vγ9Vδ2 T Cells in Science Translational Medicine
ImCheck Publishes Comprehensive Overview of the DevelopmentResults of Its First-in-class Cancer Immunotherapeutic Targeting BTN3A to…
Sorrento Announces That COVISTIX™ (COVID-19 Virus Rapid Antigen Detection Test) Has Received a CE Mark and Registration of the Device
COVISTIX has received CE mark and marketing authorization from FAMHP (Federal Agency for Medicines and…
An All-New Custom Galaxy Experience: Introducing the Samsung Galaxy Z Flip3 Bespoke Edition and Galaxy Watch4 Bespoke Studio
Canadians can design their unique Galaxy Z Flip3 5G or Galaxy Watch4 with the Bespoke…
Samsung and Maison Kitsuné Unveil a Special Edition of the Galaxy Watch4 and Buds2
Independent fashion house Maison Kitsuné’s signature Fox logo and playful style come to life on…
HERE launches Intelligent Speed Assistance map for automakers to comply with EU regulation
HERE ISA Map provides fresh and accurate speed limit information, with comprehensive coverage across the…
ZL-1102, Zai Lab’s Internally Developed Novel Human VH Antibody Fragment, Achieved Proof of Concept in Phase 1b Psoriasis Study
Topical therapy with ZL-1102 resulted in clinical improvement in local PASI score, erythema and scaling,…